The lipid profile and mortality risk in elderly type 2 diabetic patients: A ten-year follow-up study (ZODIAC-13)

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  van Hateren, Kornelis J J ^a   Landman, Gijs W D ^a   Kleefstra, Nanne ^a,b   Logtenberg, Susan J J ^a   Groenier, Klaas H ^c   Kamper, Adriaan M ^a   Houweling, Sebastiaan T ^b,d   Bilo, Henk J G ^a,c  

^a ISALA HOSPITAL   (Netherlands)

^b LANGERHANS MEDICAL RESEARCH GROUP   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d General Practice Sleeuwijk ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; NETHERLANDS; RISK FACTOR; TIME;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; MALE; NETHERLANDS; RISK FACTORS; TIME FACTORS;

EID: 77949520871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008464     Document Type: Article

References (22)

1. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, et al. (1998) United Kingdom Prospective Diabetes Study Group. UK Prospective Diabetes Study 23: risk factors for coronary artery disease in non-insulin dependent diabetes. BMJ 316: 823-828.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screenend in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444.
3. Costa J, Borges M, David C, Vaz Carneiro A (2006) Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomized controlled trials. BMJ 332: 1115-1124.
4. Cholesterol Treatment Trialists' (CTT) Collaborators (2008) Efficacy of cholesterol-lowering therapy in 18.686 people with diabetes in 14 randomized trials of statins: a meta-analysis. Lancet 371: 117-125.
5. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 10: S1-S78.
6. Rutten GEHM, De Grauw WJC, Nijpels G, Goudswaard AN, Uitewaal PJM, et al. (2006) NHG-Standaard Diabetes mellitus type 2. Huisarts Wet 49: 137-152. [in Dutch].
7. Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110: 227-239.
8. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 360: 1623-1630.
9. Iversen A, Jensen JS, Scharling H, Schnohr P (2009) Hypercholesterolaemia and risk of coronary heart disease in the elderly: impact of age. The Copenhagen City Heart Study. Eur J Intern Med 20: 139-144.
10. Anderson KM, Castelli WP, Levy D (1987) Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 257: 2176-2180.
11. Weverling-Rijnsburger AWE, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, et al. (1997) Total cholesterol and risk of mortality in the oldest old. Lancet 350: 1119-1123.
12. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, et al. (2001) Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 358: 351-355.
13. Brescianini S, Maggi S, Farchi G, Mariotti S, Di Carlo A, et al. (2003) Low total cholesterol and increased risk of dying: are low levels clinical warning signs in the elderly? Results from the Italian Longitudinal Study on Aging. J Am Geriatr Soc 51: 991-996.
14. Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, et al. (2005) Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc 53: 219-226.
15. Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Rischen RO, Meyboom-de Jong B (2005) Shared care with task delegation to nurses for type 2 diabetes, a prospective observational study. Neth J Med 63: 103-110.
16. Friedewald WT, Levy RI, Fredickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
17. Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, et al. (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321: 412-419.
18. Selvin E, Coresh J, Brancati FL (2006) The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care 29: 2415-2419.
19. De Ruijter W, Westendorp RGJ, Assendelft WJJ, Den elzen WPJ, De Craen AJM, et al. (2009) Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338: a3083.
20. Brown AF, Mangione CM, Saliba D, Sarkisian CA (2003) Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 51: S265-S280.
21. Durso SC (2006) Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA 295: 1935-1940.
22. Heart protection study collaborative group (2003) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361: 2005-2016.